Just wondering if we could take two birds with one stone here:...

Just wondering if we could take two birds with one stone here: Zynerba has just started its Phase 2 trial for Zygel, a synthetic cannabidiol formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin to target autism spectrum disorder..(fragile X syndrome) ....you could have 'em settled and with a peachy skin. BTXs would certainly be first covered by insurance and ready for prescription, it'd be pair to multi-indications targeting blockbusters of the kind of Humira and Cosentyx.

https://clinicaltrials.gov/ct2/show/NCT03802799?term=zynerba&rank=1

do not advertise external links/companies/news/216010/zynerba-pharmaceuticals-launches-phase-2-trial-of-zygel-in-autism-spectrum-disorder-216010.html